Diane E. Shevell

2.5k citations

32 papers · 1.3k indexed · h-index 17

Impact in

Hepatology top 5%
- Liver physiology and pathology
Epidemiology top 10%
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 7
- Liver physiology and pathology 4
- Liver Diseases and Immunity 4
- Liver Disease and Transplantation 3
Immunology and Allergy 2

Co-authors: Graham C. Walker Nam‐Hai Chua Tim Kunkel M.A. Karsdal Edgar D. Charles Bruce Demple Rohit Loomba Giridhar Tirucherai
Journals: Journal of Bacteriology (3 papers)Annals of the Rheumatic Diseases (2 papers)Clinical Gastroenterology and Hepatology (2 papers)Journal of Hepatology (2 papers)JHEP Reports (2 papers)
Partner nations: United States Denmark Sweden

In The Last Decade

Diane E. Shevell

32 papers receiving 1.3k citations

Peers

Countries citing papers authored by Diane E. Shevell

Since Specialization

Citations

This map shows the geographic impact of Diane E. Shevell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Shevell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Shevell more than expected).

Fields of papers citing papers by Diane E. Shevell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane E. Shevell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Shevell. The network helps show where Diane E. Shevell may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Diane E. Shevell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diane E. Shevell Line = papers co-authored together Diane E. Shevell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	POS1129 IN VITRO EVIDENCE DEMONSTRATES THAT AFIMETORAN (BMS-986256), AN EQUIPOTENT TLR7/8 DUAL ANTAGONIST, HAS STEROID-SPARING POTENTIAL IN THE CLINIC Annals of the Rheumatic Diseases ·Qihong Zhao, Hsu Zarni Maung, Gary L. Schieven, Hong Qiu, Rui Zhang, Mary Ellen Cvijic, Sotomi Goto, Manoj Chiney, Diane E. Shevell, Ihab Girgis, Frédéric Baribaud, Rapoport SSh, L. Braun Parvez	2023	1
2	Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study Clinical Gastroenterology and Hepatology ·Rohit Loomba, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Stephen A. Harrison, Eric Lawitz, Nadege Gunn, Kento Imajo, Natarajan Ravendhran, Takemi Akahane, Ivon Buitrago Villanueva, Masayuki Yamaguchi, Ho-Joong Yoon, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Manal F. Abdelmalek	2023	59
3	Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study Clinical Gastroenterology and Hepatology ·Manal F. Abdelmalek, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Eric Lawitz, Stephen A. Harrison, Ira M. Jacobson, Kento Imajo, Nadege Gunn, Dina Halegoua‐DeMarzio, Takemi Akahane, Ivon Buitrago Villanueva, Masayuki Yamaguchi, Ho-Joong Yoon, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Rohit Loomba	2023	65
4	The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis Contemporary Clinical Trials ·Manal F. Abdelmalek, Edgar D. Charles, Arun J. Sanyal, Stephen A. Harrison, Brent A. Neuschwander‐Tetri, Zachary Goodman, David Gazzaniga, M.A. Karsdal, Atsushi Nakajima, Shuyan Du, Giridhar Tirucherai, George Klinger, Johanna Mora, Masayuki Yamaguchi, Diane E. Shevell, Rohit Loomba	2021	54
5	SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH Hepatology Communications ·Yi Luo, Samir Wadhawan, Alex Greenfield, Benjamin E. Decato, Abdul M. Oseini, М.В. Романенко, Diane E. Shevell, John Ryan Thompson, Gábor Járai, Edgar D. Charles, Arun J. Sanyal	2021	56
6	Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis JHEP Reports ·Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Peder Frederiksen, Diana Julie Leeming, Diane E. Shevell, Lise Lotte Gluud, M.A. Karsdal, Guruprasad P. Aithal, Jörn M. Schattenberg	2021	33
7	Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis JHEP Reports ·Yi Luo, Benjamin E. Decato, Edgar D. Charles, Diane E. Shevell, Musie T Tsehaye, Petia Shipkova, Sen Osman, Giridhar Tirucherai, Arun J. Sanyal	2021	16
8	BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial Hepatology ·Eric Lawitz, Diane E. Shevell, Giridhar Tirucherai, Shuyan Du, Elensia Obe Liem, Uma Kavita, Lenka Ingrová, Fred Poordad, M.A. Karsdal, Mette Juul Nielsen, Zachary Goodman, Edgar D. Charles	2021	71
9	PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD Hepatology Communications ·青木功, A.K. Farhad Ahmed, Alton B. Farris, Shelley Caltharp, Rebecca Cleeton, Olena Sytko, Diane E. Shevell, M.A. Karsdal, Mette Juul Nielsen, Diana Julie Leeming, Miriam B. Vos	2021	6
10	Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity Kidney International Reports ·M Puletto, John C. Lieske, George G. Klee, Sanjay Kumar, Pietro Actis, Jorge A. Prieto, Shane A. Bobart, Diane E. Shevell, Michael A. Maldonado, Jonathan P. Troost, Marie C. Hogan	2020	14
11	Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants Clinical Pharmacology in Drug Development ·Rosy Carranza, Shalabh Singhal, Diane E. Shevell, Huadong Sun, Jenny Xie, Helen -. Toxopeus, 英彦谷村, Santanu Dutta, Elizabeth Ludwig, Hannah Huang, Dejan Tabakavić, Aberra Fura, John Throup, Ihab Girgis	2020	1
12	Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases Autoimmunity Reviews ·M.A. Karsdal, Virginia B. Kraus, Diane E. Shevell, Anne‐Christine Bay‐Jensen, Jörn M. Schattenberg, Rambabu Surabattula, Detlef Schuppan	2020	22
13	High-Throughput Doppler Toolbox for Preclinical Drug Development JALA Journal of the Association for Laboratory Automation ·Karim Azer, Qinfei Du, Christopher Tong, EmmanuelE Esezobor, Conner S. Philson, Diane E. Shevell, Matthew Walker	2010	2
14	Small Molecule Antagonists of Complement Receptor Type 3 Block Adhesion and Adhesion-Dependent Oxidative Burst in Human Polymorphonuclear Leukocytes Journal of Pharmacology and Experimental Therapeutics ·Vinay S. Bansal, Sanskruti Vaidya, Luis Ángel Velázquez Palomino, D Maurel, Diane E. Shevell, Schleupner Cj, Patricia A. Detmers	2003	12
15	Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice The Journal of Immunology ·Patricia A. Detmers, Melba Hernandez, John S. Mudgett, Adam Walczak, Charlotte Burton, Steven S. Mundt, Sam Chun, D. Fletcher, Deborah Card, JeanMarie Lisnock, Xavier Armengol, James D. Bergstrom, Diane E. Shevell, Anne Hermanowski‐Vosatka, Carl P. Sparrow, Yu‐Sheng Chao, Daniel J. Rader, Samuel D. Wright, Ellen Puré	2000	177
16	Cell Wall Alterations in the Arabidopsis emb30 Mutant The Plant Cell ·Diane E. Shevell, Tim Kunkel, Nam‐Hai Chua	2000	72
17	EMB30 is essential for normal cell division, cell expansion, and cell adhesion in Arabidopsis and encodes a protein that has similarity to Sec7 Cell ·Diane E. Shevell	1994	252
18	The cDNA Sequence of Two MADS Box Proteins in Petunia PLANT PHYSIOLOGY ·Anil Kush, Alan Brunelle, Diane E. Shevell, N H Chua	1993	40
19	A region of the Ada DNA-repair protein required for the activation of ada transcription is not necessary for activation of alkA. Proceedings of the National Academy of Sciences ·Diane E. Shevell, Graham C. Walker	1991	18
20	Resistance to alkylation damage in Escherichia coli: Role of the Ada protein in induction of the adaptive response Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Diane E. Shevell, Anderson Matheus de Sousa Lima, H. A. Roloff	1990	42

About Diane E. Shevell

Diane E. Shevell is a scholar working on Hepatology, Immunology and Allergy, Epidemiology, Immunology and Molecular Biology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), DNA Repair Mechanisms (4 papers), Liver physiology and pathology (4 papers), Bacterial Genetics and Biotechnology (4 papers), Liver Diseases and Immunity (4 papers), Diet, Metabolism, and Disease (3 papers), Liver Disease and Transplantation (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). The work is most often cited by research in Hepatology (173 citations), Epidemiology (360 citations), Cell Biology (166 citations), Molecular Biology (692 citations) and Plant Science (311 citations). Diane E. Shevell has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Graham C. Walker, Nam‐Hai Chua, Tim Kunkel, M.A. Karsdal, Edgar D. Charles, Bruce Demple, Rohit Loomba, Giridhar Tirucherai, Arun J. Sanyal and Zachary Goodman. Their work appears in journals such as Journal of Bacteriology, Annals of the Rheumatic Diseases, Clinical Gastroenterology and Hepatology, Journal of Hepatology and JHEP Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact